These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 35484429)
1. Oxytocin infusion rates for maintaining uterine tone during non-elective cesarean section in laboring patients: a randomized, controlled trial. Mohta M; Siddiqui S; Chilkoti GT; Agarwal R J Anesth; 2022 Aug; 36(4):456-463. PubMed ID: 35484429 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of different infusion rates of oxytocin for maintaining uterine tone during elective caesarean section: A randomised double blind trial. Mohta M; Chowdhury RB; Tyagi A; Agarwal R Anaesth Intensive Care; 2021 May; 49(3):183-189. PubMed ID: 33934618 [TBL] [Abstract][Full Text] [Related]
3. Utilization of carbetocin for prevention of postpartum hemorrhage after cesarean section: a randomized clinical trial. Borruto F; Treisser A; Comparetto C Arch Gynecol Obstet; 2009 Nov; 280(5):707-12. PubMed ID: 19229549 [TBL] [Abstract][Full Text] [Related]
4. The ED90 of prophylactic oxytocin infusion after delivery of the placenta during cesarean delivery in laboring compared with nonlaboring women: an up-down sequential allocation dose-response study. Lavoie A; McCarthy RJ; Wong CA Anesth Analg; 2015 Jul; 121(1):159-164. PubMed ID: 25902327 [TBL] [Abstract][Full Text] [Related]
5. Intravenous oxytocin dosing regimens for postpartum hemorrhage prevention following cesarean delivery: a systematic review and meta-analysis. Phung LC; Farrington EK; Connolly M; Wilson AN; Carvalho B; Homer CSE; Vogel JP Am J Obstet Gynecol; 2021 Sep; 225(3):250.e1-250.e38. PubMed ID: 33957113 [TBL] [Abstract][Full Text] [Related]
6. Intramyometrial and intravenous oxytocin compared to intravenous carbetocin for prevention of postpartum hemorrhage in elective cesarean section-A quasi-randomized controlled phase IV non-inferiority interventional trial. Brun R; Meier L; Kapfhammer E; Zimmermann R; Ochsenbein-Kölble N; Haslinger C Acta Obstet Gynecol Scand; 2024 Sep; 103(9):1838-1846. PubMed ID: 38952085 [TBL] [Abstract][Full Text] [Related]
7. Effect of a High-Rate Versus a Low-Rate Oxytocin Infusion for Maintaining Uterine Contractility During Elective Cesarean Delivery: A Prospective Randomized Clinical Trial. Duffield A; McKenzie C; Carvalho B; Ramachandran B; Yin V; El-Sayed YY; Riley ET; Butwick AJ Anesth Analg; 2017 Mar; 124(3):857-862. PubMed ID: 28212181 [TBL] [Abstract][Full Text] [Related]
8. Oxytocin at Elective Cesarean Delivery: A Dose-Finding Study in Pregnant People With Twin Pregnancy. Peska E; Balki M; Pfeifer W; Maxwell C; Ye XY; Downey K; Carvalho JCA Anesth Analg; 2024 Apr; 138(4):814-820. PubMed ID: 36480452 [TBL] [Abstract][Full Text] [Related]
9. Weight-based versus fixed dose oxytocin infusion for preventing uterine atony during cesarean section in laboring patients: A randomized trial. Tyagi A; Bodh P; Mohta M; Gupta B Int J Gynaecol Obstet; 2024 Mar; 164(3):985-991. PubMed ID: 37715535 [TBL] [Abstract][Full Text] [Related]
10. The ED Qian XW; Drzymalski DM; Lv CC; Guo FH; Wang LY; Chen XZ BMC Pregnancy Childbirth; 2019 Dec; 20(1):6. PubMed ID: 31892352 [TBL] [Abstract][Full Text] [Related]
11. Use of additional oxytocin to reduce blood loss at elective caesarean section: A randomised control trial. Güngördük K; Asicioglu O; Celikkol O; Olgac Y; Ark C Aust N Z J Obstet Gynaecol; 2010 Feb; 50(1):36-9. PubMed ID: 20218995 [TBL] [Abstract][Full Text] [Related]
12. Prophylactic Administration of Uterotonics to Prevent Postpartum Hemorrhage in Women Undergoing Cesarean Delivery for Arrest of Labor: A Randomized Controlled Trial. Balki M; Downey K; Walker A; Seaward G; Carvalho JCA Obstet Gynecol; 2021 Mar; 137(3):505-513. PubMed ID: 33543897 [TBL] [Abstract][Full Text] [Related]
13. Carbetocin for preventing postpartum haemorrhage. Su LL; Chong YS; Samuel M Cochrane Database Syst Rev; 2012 Feb; (2):CD005457. PubMed ID: 22336812 [TBL] [Abstract][Full Text] [Related]
14. Oxytocin bolus versus oxytocin bolus and infusion for control of blood loss at elective caesarean section: double blind, placebo controlled, randomised trial. Sheehan SR; Montgomery AA; Carey M; McAuliffe FM; Eogan M; Gleeson R; Geary M; Murphy DJ; BMJ; 2011 Aug; 343():d4661. PubMed ID: 21807773 [TBL] [Abstract][Full Text] [Related]
15. Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis. Gallos ID; Papadopoulou A; Man R; Athanasopoulos N; Tobias A; Price MJ; Williams MJ; Diaz V; Pasquale J; Chamillard M; Widmer M; Tunçalp Ö; Hofmeyr GJ; Althabe F; Gülmezoglu AM; Vogel JP; Oladapo OT; Coomarasamy A Cochrane Database Syst Rev; 2018 Dec; 12(12):CD011689. PubMed ID: 30569545 [TBL] [Abstract][Full Text] [Related]
16. Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage. Westhoff G; Cotter AM; Tolosa JE Cochrane Database Syst Rev; 2013 Oct; (10):CD001808. PubMed ID: 24173606 [TBL] [Abstract][Full Text] [Related]
17. Ten units intravenous oxytocin over 2-4 h is as effective as 30 units over 8-12 h in preventing postpartum hemorrhage after cesarean section: A randomized controlled trial. Cecilia M; Vijayaselvi R; Bansal R; Lakshmi L; Jose R Indian J Pharmacol; 2018; 50(5):279-283. PubMed ID: 30636832 [TBL] [Abstract][Full Text] [Related]
18. Carbetocin at elective Cesarean delivery: a randomized controlled trial to determine the effective dose, part 2. Anandakrishnan S; Balki M; Farine D; Seaward G; Carvalho JC Can J Anaesth; 2013 Nov; 60(11):1054-60. PubMed ID: 24158878 [TBL] [Abstract][Full Text] [Related]
19. Up-down determination of the ED(90) of oxytocin infusions for the prevention of postpartum uterine atony in parturients undergoing Cesarean delivery. George RB; McKeen D; Chaplin AC; McLeod L Can J Anaesth; 2010 Jun; 57(6):578-82. PubMed ID: 20238255 [TBL] [Abstract][Full Text] [Related]
20. Comparison of carbetocin and oxytocin infusions in reducing the requirement for additional uterotonics or procedures in women at increased risk of postpartum haemorrhage after Caesarean section. Tse KY; Yu FNY; Leung KY Hong Kong Med J; 2020 Oct; 26(5):382-389. PubMed ID: 33028723 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]